NASDAQ:GNPX - Genprex News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.79 -0.01 (-0.56 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$1.7913
Today's Range$1.7913 - $1.86
52-Week Range$0.95 - $19.45
Volume13,893 shs
Average Volume92,611 shs
Market Capitalization$26.99 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Genprex (NASDAQ GNPX) News Headlines

Source:
DateHeadline
Genprex IncGenprex Inc
www.bloomberg.com - March 19 at 12:14 PM
Genprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWireGenprex Inc. Discusses Plans to Expand Clinical Trials in Fight Against Cancer in Exclusive Audio Interview with NetworkNewsWire
finance.yahoo.com - March 19 at 12:14 PM
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.’s Innovative Approach to Gene TherapyNetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.’s Innovative Approach to Gene Therapy
finance.yahoo.com - March 15 at 12:10 PM
NetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene TherapyNetworkNewsAudio Announces Audio Press Release (APR) on Genprex Inc.'s Transformative Work in Gene Therapy
finance.yahoo.com - March 15 at 12:10 PM
-$0.18 EPS Expected for Genprex Inc (GNPX) This Quarter-$0.18 EPS Expected for Genprex Inc (GNPX) This Quarter
www.americanbankingnews.com - March 15 at 2:15 AM
NetworkNewsWire Announces Publication on Gene Therapys Promise for Improving Patient Treatments and Market ProfitabilityNetworkNewsWire Announces Publication on Gene Therapy's Promise for Improving Patient Treatments and Market Profitability
www.marketwatch.com - March 14 at 12:14 PM
NetworkNewsWire Announces Publication on Gene Therapy’s Promise for Improving Patient Treatments and Market ProfitabilityNetworkNewsWire Announces Publication on Gene Therapy’s Promise for Improving Patient Treatments and Market Profitability
finance.yahoo.com - March 14 at 12:14 PM
Genprex to Present at ARM Cell & Gene Therapy Investor Day in New York CityGenprex to Present at ARM Cell & Gene Therapy Investor Day in New York City
finance.yahoo.com - March 14 at 12:14 PM
Genprex Strengthens Senior Team and Continues to Advance OperationsGenprex Strengthens Senior Team and Continues to Advance Operations
finance.yahoo.com - February 27 at 12:05 PM
Genprex Appoints John N. Bonfiglio, PhD, to Board of DirectorsGenprex Appoints John N. Bonfiglio, PhD, to Board of Directors
finance.yahoo.com - February 19 at 12:13 PM
Genprex to Present at NobleConXV in Fort Lauderdale, FloridaGenprex to Present at NobleConXV in Fort Lauderdale, Florida
finance.yahoo.com - January 23 at 11:09 AM
Genprex to Present at Biotech Showcase™ 2019 in San FranciscoGenprex to Present at Biotech Showcase™ 2019 in San Francisco
finance.yahoo.com - January 3 at 11:11 AM
Are Insiders Buying Genprex, Inc. (NASDAQ:GNPX) Stock?Are Insiders Buying Genprex, Inc. (NASDAQ:GNPX) Stock?
finance.yahoo.com - December 25 at 3:30 PM
Is Small-Cap Outperformance Dead? Hardly!Is Small-Cap Outperformance Dead? Hardly!
seekingalpha.com - December 21 at 11:00 AM
Genprex to Launch Investors Website and Increase Emphasis on Investor Relations in 2019Genprex to Launch Investors Website and Increase Emphasis on Investor Relations in 2019
finance.yahoo.com - December 12 at 12:56 PM
Genprex to Present at the 11th Annual LD Micro Main EventGenprex to Present at the 11th Annual LD Micro Main Event
finance.yahoo.com - December 3 at 11:00 AM
Genprex Provides Clinical and Corporate Update for Third Quarter 2018Genprex Provides Clinical and Corporate Update for Third Quarter 2018
finance.yahoo.com - November 20 at 10:48 AM
Genprex Appoints Jan Stevens, RN, as Vice President of Clinical OperationsGenprex Appoints Jan Stevens, RN, as Vice President of Clinical Operations
finance.yahoo.com - October 30 at 10:39 AM
Genprex™ Taps Aldevron to Supply TUSC2 Plasmid DNA for Oncoprex Clinical Development ProgramGenprex™ Taps Aldevron to Supply TUSC2 Plasmid DNA for Oncoprex Clinical Development Program
finance.yahoo.com - September 27 at 9:52 AM
Maxim Group Starts Genprex (GNPX) at BuyMaxim Group Starts Genprex (GNPX) at Buy
www.streetinsider.com - September 25 at 9:42 AM
Genprex amends options to license additional cancer fighting technologies from the University of Texas MD Anderson Cancer CenterGenprex amends options to license additional cancer fighting technologies from the University of Texas MD Anderson Cancer Center
seekingalpha.com - August 28 at 9:30 AM
Genprex to Present at Upcoming Investor ConferencesGenprex to Present at Upcoming Investor Conferences
finance.yahoo.com - August 21 at 9:18 AM
Genprex Provides Clinical and Corporate Update for Second Quarter 2018Genprex Provides Clinical and Corporate Update for Second Quarter 2018
finance.yahoo.com - August 15 at 9:13 AM
Genprex Updates Agreement with University of Texas MD Anderson Cancer Center to Resume Patient Enrollment in Phase I/II Study Evaluating Oncoprex/Erlotinib Combination Therapy ...Genprex Updates Agreement with University of Texas MD Anderson Cancer Center to Resume Patient Enrollment in Phase I/II Study Evaluating Oncoprex/Erlotinib Combination Therapy ...
www.businesswire.com - August 2 at 3:21 PM
Genprex Updates Agreement with University of Texas MD Anderson Cancer Center to Resume Patient Enrollment in Phase I/II Study Evaluating Oncoprex/Erlotinib Combination Therapy in Non-Small Cell Lung CancerGenprex Updates Agreement with University of Texas MD Anderson Cancer Center to Resume Patient Enrollment in Phase I/II Study Evaluating Oncoprex/Erlotinib Combination Therapy in Non-Small Cell Lung Cancer
finance.yahoo.com - August 2 at 8:58 AM
Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in Combination with ImmunotherapiesGenprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in Combination with Immunotherapies
finance.yahoo.com - July 26 at 3:22 PM
Genprex To Present At The Singular Research Summer Solstice 2018 ConferenceGenprex To Present At The Singular Research Summer Solstice 2018 Conference
finance.yahoo.com - July 19 at 8:27 AM
Diamond Equity Research Initiates Coverage on Genprex Inc. (NASDAQ: GNPX) with a Valuation of $13 Per ShareDiamond Equity Research Initiates Coverage on Genprex Inc. (NASDAQ: GNPX) with a Valuation of $13 Per Share
finance.yahoo.com - July 2 at 3:20 PM
Genprex up 16% as it selects clinic for OncoprexGenprex up 16% as it selects clinic for Oncoprex
seekingalpha.com - June 26 at 3:20 PM
Genprex Selects 4Clinics To Provide Clinical And Regulatory Support For Oncoprex Development ProgramGenprex Selects 4Clinics To Provide Clinical And Regulatory Support For Oncoprex Development Program
finance.yahoo.com - June 26 at 3:20 PM
Genprex Engages WIRB-Copernicus Group, Inc. To Provide Clinical Trial Services To Support Oncoprex Clinical Trial ProgramGenprex Engages WIRB-Copernicus Group, Inc. To Provide Clinical Trial Services To Support Oncoprex Clinical Trial Program
finance.yahoo.com - May 31 at 3:18 PM
Genprex (Nasdaq: GNPX) To Ring The Nasdaq Stock Market Closing BellGenprex (Nasdaq: GNPX) To Ring The Nasdaq Stock Market Closing Bell
finance.yahoo.com - May 29 at 3:18 PM
Genprex To Present At Upcoming Investor And Industry ConferencesGenprex To Present At Upcoming Investor And Industry Conferences
finance.yahoo.com - May 23 at 3:18 PM
EBIO Gets New Name, Time To Check CHEK, ABAX Snapped Up, GNPX Up 34% In 2 DaysEBIO Gets New Name, Time To Check CHEK, ABAX Snapped Up, GNPX Up 34% In 2 Days
www.nasdaq.com - May 17 at 6:27 AM
We Believe Genprex Is A Disaster In The MakingWe Believe Genprex Is A Disaster In The Making
seekingalpha.com - May 9 at 3:17 PM
Genprex Selects Accenture To Support Acceleration Of Oncoprex Clinical Development ProgramGenprex Selects Accenture To Support Acceleration Of Oncoprex Clinical Development Program
finance.yahoo.com - May 8 at 3:17 PM
Genprex Announces $10 Million Private PlacementGenprex Announces $10 Million Private Placement
finance.yahoo.com - May 7 at 3:17 PM
Genprex To Present At 2018 Disruptive Growth & Healthcare ConferenceGenprex To Present At 2018 Disruptive Growth & Healthcare Conference
finance.yahoo.com - May 7 at 3:17 PM
Genprex Shares Are Up 260% This Week: Here Are A Few Things To ConsiderGenprex Shares Are Up 260% This Week: Here Are A Few Things To Consider
www.msn.com - April 27 at 3:16 PM
Traders News Source: Genprex, New IPO in Biotech Generates Investor Interest with Lung Cancer ProgramTraders News Source: Genprex, New IPO in Biotech Generates Investor Interest with Lung Cancer Program
www.finanznachrichten.de - April 26 at 3:16 PM
Genprex, New IPO in Biotech Generates Investor Interest with Lung Cancer ProgramGenprex, New IPO in Biotech Generates Investor Interest with Lung Cancer Program
finance.yahoo.com - April 26 at 3:16 PM
Genprex Expands Operations to Cambridge, MassGenprex Expands Operations to Cambridge, Mass
finance.yahoo.com - April 25 at 3:16 PM
Austin cancer-fighting company Genprex names new presidentAustin cancer-fighting company Genprex names new president
www.bizjournals.com - April 17 at 5:22 AM
Genprex Provides Clinical and Corporate UpdateGenprex Provides Clinical and Corporate Update
finance.yahoo.com - April 16 at 3:15 PM
Genprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene TherapyGenprex Appoints Julien Pham, MD, MPH As President To Lead Commercialization Of Oncoprex Immunogene Therapy
finance.yahoo.com - April 11 at 3:15 PM
Genprex (GNPX) Stock: May Offer Significant Growth OpportunityGenprex (GNPX) Stock: May Offer Significant Growth Opportunity
finance.yahoo.com - April 10 at 3:15 PM
Genprex Announces Closing of Initial Public OfferingGenprex Announces Closing of Initial Public Offering
www.bizjournals.com - April 6 at 12:36 PM
Genprex Announces Pricing of Initial Public Offering of Common StockGenprex Announces Pricing of Initial Public Offering of Common Stock
finance.yahoo.com - April 6 at 12:36 PM
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Featured Article: What is a Swap?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel